Clinical Trials List
Protocol NumberMEK113487
Not yet recruiting
2010-08-06 - 2012-07-13
Phase II
Terminated1
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Shih-Jen Chen Division of Ophthalmology
- Ming-Huang Chen Division of Hematology & Oncology
- Yee Chao Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
150 participants
